BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15194224)

  • 1. Walker 256 tumor MHC class I expression during the shift from A variant to the immunogenic AR variant.
    Schanoski AS; Cavalcanti TC; Campos CB; Viera-Matos AN; Rettori O; Guimarães F
    Cancer Lett; 2004 Jul; 211(1):119-27. PubMed ID: 15194224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine gene expression in Walker 256: a comparison of variants A (aggressive) and AR (regressive).
    De Almeida Salles Perroud AP; Ashimine R; De Castro GM; Guimarães F; Vieira KP; Aparecida Vilella C; Samico Cavalcanti TC; De Lima Zollner R
    Cytokine; 2006 Nov; 36(3-4):123-33. PubMed ID: 17188888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis.
    Zakharova LA; Khegai II; Sharova NP; Melnikova VI; Karpova YD; Astakhova TM; Popova NA; Ivanova LN
    Cell Immunol; 2011; 271(2):385-91. PubMed ID: 21889127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of the RT1A molecule of the class I major histocompatibility complex in a Walker 256 tumor after transplantation into Brattleboro rats with a genetic defect of arginine-vasopressin synthesis].
    Mel'nikova VI; Khegaĭ II; Afanas'eva MA; Ivanova LN; Zakharova LA
    Izv Akad Nauk Ser Biol; 2013; (1):99-102. PubMed ID: 23662467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I antigens and immune surveillance in transformed cells.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
    Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor.
    Cavalcanti TC; Gregorini CC; Guimarães F; Rettori O; Vieira-Matos AN
    Braz J Med Biol Res; 2003 Jul; 36(7):887-95. PubMed ID: 12845375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subpopulation of human basal keratinocytes has a low/negative MHC class I expression.
    Matic M
    Hum Immunol; 2005 Sep; 66(9):962-8. PubMed ID: 16360835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low immunogenicity of endothelial derivatives from rat embryonic stem cell-like cells.
    Ladhoff J; Bader M; Brösel S; Effenberger E; Westermann D; Volk HD; Seifert M
    Cell Res; 2009 Apr; 19(4):507-18. PubMed ID: 19238174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.
    Liu X; Zhang L; Zhang X; Yu H; Zhao X; Lu J; Qian G; Ge S
    Int J Oncol; 2007 Jun; 30(6):1389-96. PubMed ID: 17487359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity.
    Rickard S; Ono SJ
    Exp Mol Pathol; 2008 Dec; 85(3):147-54. PubMed ID: 18952077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forcing tumor cells to present their own tumor antigens to the immune system: a necessary design for an efficient tumor immunotherapy.
    Humphreys RE; Hillman GG; von Hofe E; Xu M
    Cell Mol Immunol; 2004 Jun; 1(3):180-5. PubMed ID: 16219165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
    Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
    Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules.
    Johansson S; Johansson M; Rosmaraki E; Vahlne G; Mehr R; Salmon-Divon M; Lemonnier F; Kärre K; Höglund P
    J Exp Med; 2005 Apr; 201(7):1145-55. PubMed ID: 15809355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of expression of MHC class I molecule in Walker 256 tumor in growth dynamics in Brattleboro rats.
    Mafanasyeva MA; Zakharova LA; Khegai II; Sharova NP; Popova NA; Ivanova LN; Melnikova VI
    Dokl Biochem Biophys; 2010; 430():11-3. PubMed ID: 20380153
    [No Abstract]   [Full Text] [Related]  

  • 17. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I down-regulation: tumour escape from immune surveillance? (review).
    Bubeník J
    Int J Oncol; 2004 Aug; 25(2):487-91. PubMed ID: 15254748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of MHC class I expression in human neuronal stem cells using viral stealth mechanism.
    Lee EM; Kim JY; Cho BR; Chung WK; Yoon BW; Kim SU; Lee BC; Hwang WS; Moon SY; Lee JS; Ahn C
    Biochem Biophys Res Commun; 2005 Jan; 326(4):825-35. PubMed ID: 15607744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.